Resverlogix Corp. (TSE:RVX – Get Free Report) shares hit a new 52-week low during mid-day trading on Friday. The stock traded as low as C$0.08 and last traded at C$0.08, with a volume of 63,264 shares trading hands. The stock had previously closed at C$0.09.
Resverlogix Trading Down 5.9%
The stock has a fifty day moving average of C$0.09 and a 200 day moving average of C$0.10. The company has a debt-to-equity ratio of -82.47, a quick ratio of 0.04 and a current ratio of 0.04. The company has a market capitalization of C$27.54 million, a PE ratio of -2.00 and a beta of -0.11.
About Resverlogix
Founded in 2001, Resverlogix is a Calgary based late-stage biotechnology company, and a world leader in epigenetics, with the goal of developing first-in-class therapies for the benefit of patients with chronic disease. Resverlogix is developing a new class of epigenetic therapies designed to regulate the expression of disease-causing genes. We aim to improve patients’ lives by restoring biological functions – altered by serious illnesses such as cardiovascular disease – back to a healthier state.
Further Reading
- Five stocks we like better than Resverlogix
- Rocket Lab’s Neutron Delay Leaves Wall Street Bullish But Raises the Stakes for 2027
- ManpowerGroup Stock Sinks on Q3 Results, But Fundamentals Stay Solid
- Does the AI Selloff Put Alphabet’s Breakout in Doubt?
- Bank Earnings Are Mixed—These 2 ETFs Offer Very Different Paths to a Recovery
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
